NeoGenomics appoints Cardoza as President & COO, Lab Ops; Wallar as President, Pharma Services

NEOGENOMICS INC

George A. Cardoza appointed President and COO, Lab Operations effective July 5, 2021; base salary $500k, bonus target 60%.
Dr. Gina M. Wallar appointed President, Pharma Services effective July 5, 2021; base salary $370k, bonus target 50%.
Cardoza awarded equity valued at $1M (7,584 restricted shares + option for 40,502 shares); Wallar awarded $250k equity.
Both appointments are internal promotions; Cardoza previously CFO and President Pharma Services, Wallar previously SVP Sales.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Gina M. Wallar

President, Pharma Services Division

NEO · NEOGENOMICS INC

Effective: 2021-07-05
Filed: July 7, 2021, 7:59 PM ET

The Company announces that Dr. Gina M. Wallar, age 46, has been appointed President, Pharma Services Division effective July 5, 2021 to replace the vacancy left by Mr. Cardoza's assumption of his new position.

Role change

George A. Cardoza

President and Chief Operating Officer, Lab Operations

NEO · NEOGENOMICS INC

Effective: 2021-07-05
Filed: July 7, 2021, 7:59 PM ET

NeoGenomics, Inc. (the “Company”) announces that George A. Cardoza, age 59, has been appointed President and Chief Operating Officer, Lab Operations effective July 5, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Gina M. Wallar was appointed as President, Pharma Services Division at NEOGENOMICS INC.

Action: appointed
Role: President, Pharma Services Division

Exact text from the filing

The Company announces that Dr. Gina M. Wallar, age 46, has been appointed President, Pharma Services Division effective July 5, 2021 to replace the vacancy left by Mr. Cardoza's assumption of his new position.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

George A. Cardoza was appointed as President and Chief Operating Officer, Lab Operations at NEOGENOMICS INC.

Action: appointed
Role: President and Chief Operating Officer, Lab Operations

Exact text from the filing

NeoGenomics, Inc. (the “Company”) announces that George A. Cardoza, age 59, has been appointed President and Chief Operating Officer, Lab Operations effective July 5, 2021.

View on SEC.gov

NEOGENOMICS INC filing history →

Source: SEC EDGAR

accession 0001077183-21-000179

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.